Literature DB >> 9532590

Identification of peptides binding to IgG in the CSF of multiple sclerosis patients.

I Cortese1, S Capone, R Tafi, L M Grimaldi, A Nicosia, R Cortese.   

Abstract

Phage displayed random peptide libraries were screened in order to identify phagotopes reacting with the IgG present in the cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients. Six families of phagotopes each composed of different isolates were identified. These phagotopes were used as reagents, to characterise IgG present in the CSF of MS patients. The following results were obtained: (a) CSF antibodies from different patients display different specificities; (b) anti-phagotope antibodies are also present in the serum of MS patients; (c) Anti-phagotope antibodies are equally frequent in the serum of MS patients and of healthy individuals; (d) some of the anti-phagotope antibodies are enriched in the CSF of MS patients. These data show that the natural antigen(s) recognised by CSF antibodies is rather common in the general population. By using the selected phagotopes as immunogens in rabbits, we have derived large quantities of anti-phagotope antisera which can provide for useful tools toward the identification of the natural antigen(s) recognised by MS CSF antibodies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9532590     DOI: 10.1177/135245859800400108

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  7 in total

1.  Intrathecally synthesized IgG in multiple sclerosis cerebrospinal fluid recognizes identical epitopes over time.

Authors:  Xiaoli Yu; Mark Burgoon; Miyoko Green; Olga Barmina; Kathryn Dennison; Tiffany Pointon; Molly Davis; Don Gilden
Journal:  J Neuroimmunol       Date:  2011-11-12       Impact factor: 3.478

2.  Antibody biomarker discovery through in vitro directed evolution of consensus recognition epitopes.

Authors:  John T Ballew; Joseph A Murray; Pekka Collin; Markku Mäki; Martin F Kagnoff; Katri Kaukinen; Patrick S Daugherty
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-12       Impact factor: 11.205

3.  Peptide reactivity between multiple sclerosis (MS) CSF IgG and recombinant antibodies generated from clonally expanded plasma cells in MS CSF.

Authors:  Xiaoli Yu; Don Gilden; Laura Schambers; Olga Barmina; Mark Burgoon; Jeffrey Bennett; Greg Owens
Journal:  J Neuroimmunol       Date:  2010-12-21       Impact factor: 3.478

4.  Screening random peptide libraries with subacute sclerosing panencephalitis brain-derived recombinant antibodies identifies multiple epitopes in the C-terminal region of the measles virus nucleocapsid protein.

Authors:  Gregory P Owens; Andrew J Shearer; Xiaoli Yu; Alanna M Ritchie; Kathryne M Keays; Jeffrey L Bennett; Donald H Gilden; Mark P Burgoon
Journal:  J Virol       Date:  2006-12       Impact factor: 5.103

5.  Proteomic strategies in multiple sclerosis and its animal models.

Authors:  Stella Elkabes; Hong Li
Journal:  Proteomics Clin Appl       Date:  2007-10-16       Impact factor: 3.494

6.  Identification of novel non-myelin biomarkers in multiple sclerosis using an improved phage-display approach.

Authors:  Andrea Cortini; Sara Bembich; Lorena Marson; Eleonora Cocco; Paolo Edomi
Journal:  PLoS One       Date:  2019-12-05       Impact factor: 3.240

Review 7.  Molecular mimicry in multiple sclerosis.

Authors:  Jane E Libbey; Lori L McCoy; Robert S Fujinami
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.